Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    July 2022
  1. SIONTIS KC, Gersh BJ, Weston SA, Jiang R, et al
    Associations of Atrial Fibrillation After Noncardiac Surgery With Stroke, Subsequent Arrhythmia, and Death : A Cohort Study.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/M22-0434.
    PubMed     Abstract available


  2. ALMHRI A, Leong DP
    In AF, CV benefits of catheter ablation vs. medical therapy may vary by age.
    Ann Intern Med. 2022;175:JC77.
    PubMed     Abstract available


    June 2022
  3. CHOI SE, Lip GYH
    USPSTF found insufficient evidence on the benefits and harms of screening adults >/=50 y for AF.
    Ann Intern Med. 2022;175:JC62.
    PubMed     Abstract available


    February 2022
  4. HUANG HK, Liu PP, Lin SM, Hsu JY, et al
    Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants : A Nationwide Analysis.
    Ann Intern Med. 2022 Feb 15. doi: 10.7326/M21-3498.
    PubMed     Abstract available


  5. COLIVICCHI F
    In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding.
    Ann Intern Med. 2022;175:JC22.
    PubMed     Abstract available


  6. SANTULLI G, Mone P
    In permanent AF with narrow QRS, AV junction ablation + CRT vs. rate-control drug therapy reduced mortality.
    Ann Intern Med. 2022;175:JC21.
    PubMed     Abstract available


    January 2022
  7. YOUSUFUDDIN M, Jahangir A
    In older patients at high risk for stroke, intensive AF screening with an implantable loop recorder did not reduce stroke.
    Ann Intern Med. 2022;175:JC8.
    PubMed     Abstract available


  8. YOUSUFUDDIN M, Jahangir A
    In adults aged 75 to 76 y, systematic AF screening reduced morbidity and mortality at 6 y.
    Ann Intern Med. 2022;175:JC9.
    PubMed     Abstract available


    December 2021
  9. WILLETT LR, Kim S
    In paroxysmal AF, first-line catheter ablation vs. antiarrhythmic drugs reduces atrial arrhythmia recurrence.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/ACPJ202112210.
    PubMed     Abstract available


    October 2021
  10. SHAH S, Garg J
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1489-1490.
    PubMed    


  11. DAWWAS GK, Barnes GD, Cuker A, Lewis JD, et al
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1490.
    PubMed    


  12. RODWIN BA
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1488-1489.
    PubMed    


  13. MANSI IA, Bhushan S, Albracht DE
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1489.
    PubMed    


    September 2021
  14. SAMPSON C
    In acute atrial flutter, adding pharmacologic before electrical cardioversion did not increase conversion to normal sinus rhythm.
    Ann Intern Med. 2021 Sep 7. doi: 10.7326/ACPJ202109210.
    PubMed     Abstract available


    August 2021
  15. PIANO MR, Hwang CL
    Holiday Heart Confirmed: Alcohol-Associated Atrial Fibrillation.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-3193.
    PubMed    



  16. Summary for Patients: Alcohol Drinking and Atrial Fibrillation.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/P21-0008.
    PubMed    


  17. MARCUS GM, Vittinghoff E, Whitman IR, Joyce S, et al
    Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-0228.
    PubMed     Abstract available


    July 2021
  18. KIM DH, Pawar A, Gagne JJ, Bessette LG, et al
    Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M20-7141.
    PubMed     Abstract available


    June 2021
  19. KARIMZAD K, Deswal A
    In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
    Ann Intern Med. 2021;174:JC69.
    PubMed     Abstract available


    April 2021
  20. GUE YX, Lip GYH
    In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events.
    Ann Intern Med. 2021;174:JC43.
    PubMed     Abstract available


    March 2021
  21. DAWWAS GK, Dietrich E, Cuker A, Barnes GD, et al
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Ann Intern Med. 2021 Mar 30. doi: 10.7326/M20-6194.
    PubMed     Abstract available


    January 2021
  22. STEINBERG DI
    In older patients with AF, low-dose edoxaban reduced stroke or systemic embolism without increasing major bleeding.
    Ann Intern Med. 2021;174:JC5.
    PubMed     Abstract available


  23. SANTULLI G
    In patients with early AF and CV conditions, early rhythm-control therapy vs. usual care reduced CV events at 5 years.
    Ann Intern Med. 2021;174:JC6.
    PubMed     Abstract available


    September 2020
  24. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Atrial Fibrillation on the Run?
    Ann Intern Med. 2020;173:CG1.
    PubMed    


  25. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    PubMed     Abstract available


    July 2020
  26. PACIULLO F, Costa C, Gresele P
    Rivaroxaban Plasma Levels and Levetiracetam: A Case Report.
    Ann Intern Med. 2020;173:71-72.
    PubMed    


    May 2020
  27. LAU WCY, Cheung CL, Man KKC, Chan EW, et al
    Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation.
    Ann Intern Med. 2020 May 19. doi: 10.7326/M19-3671.
    PubMed     Abstract available


  28. GORE M, Nagarajan V
    In adults with AF who regularly drink alcohol, a 6-month abstinence intervention reduced AF recurrence and burden.
    Ann Intern Med. 2020;172:JC53.
    PubMed     Abstract available


    April 2020
  29. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - What's the Score? Atrial Fibrillation and CHA2DS2-VASc.
    Ann Intern Med. 2020;172:CG1.
    PubMed    


    March 2020
  30. SAHA BK, Modi A, Beegle S
    Asthma From Allergy to Titanium in a Cardiac Pacemaker.
    Ann Intern Med. 2020 Mar 31. pii: 2763875. doi: 10.7326/L19-0647.
    PubMed    


  31. DUNN A
    In AF, DOACs were linked to lower risk for osteoporotic fractures at 2 years compared with VKAs.
    Ann Intern Med. 2020;172:JC35.
    PubMed    


  32. DUNN A
    In AF, DOACs were linked to lower risk for clinical fracture at 17 months compared with warfarin.
    Ann Intern Med. 2020;172:JC34.
    PubMed    


    February 2020
  33. MARX GE, Leikauskas J, Lindstrom K, Mann E, et al
    Fatal Lyme Carditis in New England: Two Case Reports.
    Ann Intern Med. 2020;172:222-224.
    PubMed    


    January 2020
  34. SANTULLI G
    In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
    Ann Intern Med. 2020;172:JC6.
    PubMed    


    October 2019
  35. BATES ER
    In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
    Ann Intern Med. 2019;171:JC47.
    PubMed    


  36. BATES ER
    In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
    Ann Intern Med. 2019;171:JC46.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: